BlackRock Investment Management’s Biostage, Inc. Common Stock BSTG Stock Holding History

BlackRock Investment Management’s Portfolio BSTG Stock Details BSTG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-1,721	Closed	-$6K	–	4245
2015 Q1	$6K	Buy	1,721 +322	+23%	+$1.1K	﹤0.01%	3838
2014 Q4	$4K	Hold	1,399	–	–	﹤0.01%	3978
2014 Q3	$11K	Buy	1,399 +115	+9%	+$941	﹤0.01%	3650
2014 Q2	$13K	Sell	1,284 -20,638	-94%	-$176K	﹤0.01%	3553
2014 Q1	$199K	Buy	21,922 +42	+0.2%	+$249	﹤0.01%	3233
2013 Q4	$104K	Buy	+21,880	New	+$102K	﹤0.01%	3274

Other funds holding BSTG

State of New Jersey Common Pension Fund D Trenton, New Jersey $29.3B AUM 38.15% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

WIC

Woodmont Investment Counsel Nashville, Tennessee $1.83B AUM 25.91% 1-Year Est. Return

BlackRock Investment Management's BSTG Position: Q2 2015 in Review

BlackRock Investment Management sold out of Biostage, Inc. Common Stock (BSTG) in Q2 2015, closing a stake of 1,721 shares — an estimated $6K sold.

BlackRock Investment Management first reported a position in BSTG in Q4 2013 and held it in 6 quarters. The position peaked at $199K in Q1 2014. 32 funds tracked by Wall St. Rank hold BSTG as of Q2 2015.

BlackRock Investment Management reported no remaining Biostage, Inc. Common Stock position as of Q2 2015 after selling out during the quarter.
BlackRock Investment Management sold 1,721 Biostage, Inc. Common Stock shares in Q2 2015, an estimated $6K.
BlackRock Investment Management first reported a position in Biostage, Inc. Common Stock in Q4 2013 and held it in 6 quarters.
BlackRock Investment Management's Biostage, Inc. Common Stock position peaked at $199K in Q1 2014.
32 funds tracked by Wall St. Rank held Biostage, Inc. Common Stock as of Q2 2015.

Based on BlackRock Investment Management's 13F filing for Q2 2015, filed 7 Aug 2015.